Vulnerability Details : CVE-2017-10045
Vulnerability in the PeopleSoft Enterprise PeopleTools component of Oracle PeopleSoft Products (subcomponent: Integration Broker). Supported versions that are affected are 8.54 and 8.55. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise PeopleSoft Enterprise PeopleTools. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all PeopleSoft Enterprise PeopleTools accessible data. CVSS 3.0 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:N/A:N).
Vulnerability category: Bypass
Products affected by CVE-2017-10045
- cpe:2.3:a:oracle:peoplesoft_enterprise_peopletools:8.55:*:*:*:*:*:*:*
- cpe:2.3:a:oracle:peoplesoft_enterprise_peopletools:8.54:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2017-10045
0.13%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 49 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2017-10045
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
2.6
|
LOW | AV:N/AC:H/Au:N/C:P/I:N/A:N |
4.9
|
2.9
|
NIST | |
5.3
|
MEDIUM | CVSS:3.0/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:N/A:N |
1.6
|
3.6
|
NIST |
References for CVE-2017-10045
-
http://www.securityfocus.com/bid/99806
Oracle PeopleSoft Enterprise PeopleTools CVE-2017-10045 Remote Security VulnerabilityThird Party Advisory;VDB Entry
-
http://www.securitytracker.com/id/1038932
Oracle PeopleSoft Products Multiple Flaws Let Remote Users Access and Modify Data and Deny Service and Let Local Users Access Data on the Target System - SecurityTrackerThird Party Advisory;VDB Entry
-
http://www.oracle.com/technetwork/security-advisory/cpujul2017-3236622.html
Oracle Critical Patch Update - July 2017Patch;Vendor Advisory
Jump to